Jerez de la Frontera, 11 October 2026. From 7 to 9 October, Myukura took part in the fourth edition of Canarias Destino Startup 2026, held at the Alfredo Kraus Auditorium in Las Palmas de Gran Canaria.
The event brought together 35 startups, along with investors, companies, institutional representatives and professionals from the innovation ecosystem, becoming a space to present new technologies, explore collaboration opportunities and analyse the challenges of business growth.
For MYULAB INNOVATION, S.L., the technology company responsible for developing Myukura, taking part was an opportunity to present the progress of its technology, test its proposal against the market and build new strategic relationships outside Andalusia.
From Jerez to the Canaries: a technology proposal to transform clinical documentation
Myukura’s participation focused on one of the challenges of healthcare digitalisation: the growing administrative burden borne by clinical professionals.
Writing reports, updating records, documenting consultations and interacting with different IT systems take up a significant part of the working day.
Although digitalisation has improved access to and organisation of health information, it has also introduced new processes that require constant intervention from the professional.
Myukura was born with the aim of reducing that burden through an artificial intelligence infrastructure capable of fitting into existing clinical workflows.
Its proposal combines transcription of clinical conversations, structuring of information, assisted generation of documentation and longitudinal patient follow-up, while keeping the healthcare professional’s review and approval.
The goal is not to replace medical judgement, but to develop tools that make better use of the time devoted to patient care.
Miriam Guerra presents Myukura to the investor ecosystem
One of the central moments of the participation was Myukura’s presentation on the Canarias Destino Startup stage.
Miriam Guerra, co-founder of Myukura, set out the challenges healthcare professionals face and presented the technology vision the company is developing.
Under a central question — “Patient or screen?” — the presentation addressed how the documentation burden and the fragmentation of systems can shape the relationship between professionals and patients.
During the talk, she explained Myukura’s evolution from a documentation assistance tool towards a platform with different clinical processing capabilities, specialised artificial intelligence and local execution.
The presentation made it possible to show both the healthcare dimension of the project and its research and technology development component.
Beyond an application: specialised models and our own infrastructure
One of Myukura’s distinguishing elements is its commitment to developing its own technology rather than limiting its proposal to integrating third-party artificial intelligence models.
At MYULAB, work is under way on an architecture that combines different lines of development:
- Clinical processing and structuring. Specialised pipelines to turn conversations and unstructured information into organised documentation, making it easier for the professional to review and use.
- Specialised artificial intelligence models. Research and training of models aimed at specific tasks, such as extracting clinical information, identifying relevant entities and handling the linguistic particularities of the healthcare setting.
- Local and cloud artificial intelligence. A hybrid architecture that allows certain operations to be distributed between physical devices and cloud services, according to privacy, performance and availability needs.
- Oversight and traceability. Workflows designed to keep the professional at the centre of the process, with mechanisms for review, validation and control over the documentation generated.
This strategy reflects a long-term development vision: building a specialised technology base that can evolve, adapt to different clinical environments and progressively extend its capabilities.
Local processing as a strategic line
During the event, Myukura also showed some of its first hardware developments and local processing.
This line of research seeks to bring certain artificial intelligence capabilities closer to the healthcare setting itself, reducing the need to continuously send information to external infrastructure.
The company is exploring on-device computing architectures, compact models and audio capture and processing systems that allow it to move towards more autonomous solutions.
It is a line complementary to its cloud platform and forms part of a broader strategy for developing technology infrastructure for the healthcare sector.
Three days of connections, investment and business learning
As well as presenting its technology, the Myukura team took part in meetings and conversations with investors, entrepreneurs, companies and institutional representatives.
The sessions made it possible to look at different perspectives on the growth of technology startups, from early-stage funding to building sustainable business models.
Among the main conclusions, the importance stood out of combining technology development with commercial validation, the generation of evidence and a financial strategy consistent with the project’s maturity.
The participation also made it possible to learn about other business initiatives, identify possible avenues for collaboration and establish contacts for future conversations.
For Myukura, the event reinforced a fundamental idea: technological capability must be accompanied by an understandable value proposition, verifiable results and a commercialisation strategy oriented to the real needs of the customer.
MYULAB’s role in developing its own technology
Behind Myukura is MYULAB INNOVATION, S.L., a technology company founded in Jerez de la Frontera and focused on developing artificial intelligence solutions, specialised models and local and cloud processing architectures.
Its strategy combines applied research, software engineering and hardware development, with the goal of building technology solutions that respond to specific problems.
The company is part of international initiatives supporting technology entrepreneurship, including NVIDIA Inception, Google for Startups and Microsoft for Startups Founders Hub.
These initiatives are part of the ecosystem of resources and collaboration on which MYULAB continues to develop its projects.
Taking part in Canarias Destino Startup represents a new step in its outreach beyond Andalusia and in building relationships with the Spanish technology and business ecosystem.
Next steps: development, validation and growth
Following its participation in Canarias Destino Startup 2026, Myukura will continue to advance in three priority areas.
The first is the evolution of its clinical platform, with particular attention to the reliability of information processing, the professional’s experience and the validation of its workflows.
The second is the development of specialised models and local artificial intelligence capabilities, a strategic line for gaining more control over its technology and exploring new possibilities for on-device processing.
The third is consolidating relationships with healthcare professionals, partner organisations, companies and investors, so as to accompany technology development with a sustainable growth strategy.
Taking part in Canarias Destino Startup has made it possible to present these advances, test their direction with different players in the ecosystem and open up new collaboration opportunities.
From Jerez de la Frontera, MYULAB continues to work on a clinical artificial intelligence proposal based on specialised technology, privacy, professional oversight and in-house development.
Because the future of healthcare digitalisation does not depend solely on adding more artificial intelligence, but on making sure it responds effectively to the needs of those who work in the clinical environment every day.